• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.42% Nasdaq Up 0.43%

    PDL BioPharma, Inc. (PDLI)

    -NasdaqGS
    6.51 Down 0.17(2.59%) 1:42PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:6.68
    Open:6.59
    Bid:6.50 x 8700
    Ask:6.51 x 5600
    1y Target Est:7.00
    Beta:0.9
    Earnings Date:Aug 17 - Aug 21 (Est.)
    Day's Range:6.43 - 6.59
    52wk Range:6.38 - 10.26
    Volume:1,382,073
    Avg Vol (3m):3,755,920
    Market Cap:1.07B
    P/E (ttm):3.39
    EPS (ttm):1.92
    Div & Yield:0.60 (9.00%)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    PDLIDown 2.59%1.07B
    AMGNUp 0.18%119.16B
    SGEN 0.00%5.68B
    XOMAUp 1.73%415.89M

    Key Statistics

    Forward P/E (1 yr):8.23
    P/S (ttm):2.20
    Ex-Dividend Date:02-Dec-15

    Analysts

    Annual EPS Est (Dec-15) :2.11
    Quarterly EPS Est (Jun-15) :0.52
    Mean Recommendation*:3.0
    PEG Ratio (5 yr expected):0.23

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    PDL BioPharma, Inc. manages a portfolio of patents and royalty assets in the United States and Europe. The company is involved in the humanization of monoclonal antibodies and the discovery of a new generation of targeted treatments for cancer and... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback